Dabomb Protein Biotech (ROCO:6578) Total Long-Term Assets: NT$864.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
59 GF Score
Price NT$18.00
GF Value NT$18.13
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech Total Long-Term Assets?

Dabomb Protein Biotech ROCO:6578 +0.28% 59 Total Long-Term Assets is NT$864.8 Mil as of Jun. 2026. GuruFocus rates ROCO:6578 with a GF Score™ of 59/100 and a GF Value™ of NT$18.13 (Fairly Valued). The stock has 1 warning sign investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Dabomb Protein Biotech's Total Long-Term Assets for the quarter that ended in Jun. 2026 was NT$864.8 Mil.

Dabomb Protein Biotech Total Long-Term Assets Related Terms

Dabomb Protein Biotech Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech Total Long-Term Assets Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 934.87 937.32 623.06 661.11 870.08

Dabomb Protein Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 673.82 907.58 870.08 869.51 864.80
ROCO:6578
59GF Score
Dabomb Protein Biotech Corp ROCO:6578
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of NT$864.8 Mil mean?
Dabomb Protein Biotech (ROCO:6578) has a Total Long-Term Assets of NT$864.8 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Total Long-Term Assets too high?
Dabomb Protein Biotech's current Total Long-Term Assets is NT$864.8 Mil. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Total Long-Term Assets compare to KHC and GIS?
Dabomb Protein Biotech's Total Long-Term Assets of NT$864.8 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Consumer Packaged Goods company?
A good Total Long-Term Assets depends on the Consumer Packaged Goods industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Total Long-Term Assets is NT$864.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Fairly Valued. The stock's GF Value™ is NT$18.13, compared to a current price of NT$18.00 — trading 0.7% below its estimated fair value. The current Total Long-Term Assets is NT$864.8 Mil. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Total Long-Term Assets is NT$864.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be undervalued. The current stock price of NT$18.00 is trading 0.7% below its estimated GF Value™ of NT$18.13. GuruFocus considers Dabomb Protein Biotech to be Fairly Valued.

Key valuation signals for ROCO:6578:

  • Total Long-Term Assets: NT$864.8 Mil
  • GF Value™: NT$18.13 vs. price of NT$18.00 (0.7% below fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score

Get the complete analysis for ROCO:6578

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.00
Price
NT$18.13
GF Value